These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 18392213

  • 1. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR.
    Timely Top Med Cardiovasc Dis; 2008 Feb 04; 12():E3. PubMed ID: 18392213
    [Abstract] [Full Text] [Related]

  • 2. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR.
    Drugs Today (Barc); 2007 Nov 04; 43(11):815-26. PubMed ID: 18174967
    [Abstract] [Full Text] [Related]

  • 3. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
    Shvarts V.
    Klin Med (Mosk); 2009 Nov 04; 87(11):17-24. PubMed ID: 20143560
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.
    Yamagishi S, Nakamura K, Takeuchi M, Imaizumi T.
    Int J Clin Pharmacol Res; 2004 Nov 04; 24(4):129-34. PubMed ID: 15754918
    [Abstract] [Full Text] [Related]

  • 5. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA.
    Rev Cardiovasc Med; 2006 Nov 04; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [Abstract] [Full Text] [Related]

  • 6. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
    Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D.
    Diabetes Care; 2006 Sep 04; 29(9):2064-71. PubMed ID: 16936154
    [Abstract] [Full Text] [Related]

  • 7. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C, Monnier L.
    Horm Metab Res; 2007 Sep 04; 39(9):683-6. PubMed ID: 17846977
    [Abstract] [Full Text] [Related]

  • 8. The endothelial dysfunction in diabetes mellitus.
    Pănuş C, Moţa M, Vladu D, Vanghelie L, Răducanu CL.
    Rom J Intern Med; 2003 Sep 04; 41(1):27-33. PubMed ID: 15529582
    [Abstract] [Full Text] [Related]

  • 9. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M.
    Diabetes Care; 2008 Feb 04; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [Abstract] [Full Text] [Related]

  • 10. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J, Nadeau DA.
    J Fam Pract; 2007 Dec 04; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [Abstract] [Full Text] [Related]

  • 11. [Hyperglycemia and vascular damage role of oxidative stress].
    Esposito K, Giugliano D.
    Recenti Prog Med; 2002 Mar 04; 93(3):172-4. PubMed ID: 11942168
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
    Massi-Benedetti M, Federici MO.
    Exp Clin Endocrinol Diabetes; 1999 Mar 04; 107 Suppl 4():S120-3. PubMed ID: 10522835
    [Abstract] [Full Text] [Related]

  • 13. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z, Werstuck GH, Gerstein HC.
    Rev Cardiovasc Med; 2007 Mar 04; 8(3):145-53. PubMed ID: 17938614
    [Abstract] [Full Text] [Related]

  • 14. Association of hyperglycemia and insulin with diabetic cardiovascular complications.
    Khamaisi M, Wainstein J, Hancu N, Milicevic Z, Raz I.
    Isr Med Assoc J; 2003 Feb 04; 5(2):116-9. PubMed ID: 12674662
    [Abstract] [Full Text] [Related]

  • 15. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S.
    Expert Rev Cardiovasc Ther; 2008 Jul 04; 6(6):859-72. PubMed ID: 18570623
    [Abstract] [Full Text] [Related]

  • 16. Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
    Yosefy C.
    Acta Diabetol; 2003 Dec 04; 40 Suppl 2():S380-8. PubMed ID: 14704873
    [Abstract] [Full Text] [Related]

  • 17. [Hyperglycemia and cardiovascular events].
    Schneider CA, Gallwitz B, Hanefeld M, Leschke M, Müller-Wieland D, Zeymer U, Erdmann E.
    Dtsch Med Wochenschr; 2004 Nov 19; 129(47):2553-7. PubMed ID: 15543474
    [Abstract] [Full Text] [Related]

  • 18. [Importance of the post-prandial glycemia in the management of type 2 diabetes].
    Raguso CA, Helary C, Philippe J.
    Rev Med Suisse; 2008 Jun 04; 4(160):1383-6. PubMed ID: 18630060
    [Abstract] [Full Text] [Related]

  • 19. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF, Yan SD, Herold K, Ramsamy R, Schmidt AM.
    Endocrinol Metab Clin North Am; 2006 Sep 04; 35(3):511-24, viii. PubMed ID: 16959583
    [Abstract] [Full Text] [Related]

  • 20. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes.
    Okon EB, Chung AW, Zhang H, Laher I, van Breemen C.
    Can J Physiol Pharmacol; 2007 May 04; 85(5):562-7. PubMed ID: 17632592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.